KRAS and neoplasm: Interestingly, the hypomethylation of KRAS is decreased in LUSC, BRCA, ESCA, and LIHC, even though we found a significant upregulation of KRAS in these tumors (Figure 3H,I, Supplementary Figure S1E,F), suggesting a complex tumor microenvironment, and further mechanisms in this manner are needed.